JPMORGAN CHASE & CO - REATA PHARMACEUTICALS INC ownership

REATA PHARMACEUTICALS INC's ticker is and the CUSIP is 75615P953. A total of 6 filers reported holding REATA PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of REATA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2019$5,267,000
+91.7%
65,600
+118.7%
0.00%0.0%
Q2 2019$2,747,00030,0000.00%
Other shareholders
REATA PHARMACEUTICALS INC shareholders Q3 2019
NameSharesValueWeighting ↓
SIMPLEX TRADING, LLC 186,400$4,684,0000.01%
GROUP ONE TRADING, L.P. 87,700$2,204,0000.00%
JANE STREET GROUP, LLC 122,900$3,088,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of REATA PHARMACEUTICALS INC shareholders